
Clene Inc. Warrant
CLNNW
CLNNW: Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).
moreShow CLNNW Financials
Recent trades of CLNNW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CLNNW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CLNNW's company Twitter account
Number of mentions of CLNNW in WallStreetBets Daily Discussion
Recent insights relating to CLNNW
Recent picks made for CLNNW stock on CNBC
ETFs with the largest estimated holdings in CLNNW
Flights by private jets registered to CLNNW